Drugs / CBD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04679545 | Dec 2020 → Mar 2021 | diabetic polyneuropathy | Pure Green | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04679545 ↗ |
| Route | Other | “sublingual tablet” NCT04679545 ↗ |